ANGELA WILKE: Open Payments
NPI 1669651964 · SAN ANGELO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$217 in 11 payments from 9 companies in 2025. Trend: 2023 $175 · 2024 $348 · 2025 $217
Food & beverage: $217
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $45 |
| ABBVIE INC. | 2 | $32 |
| Sumitomo Pharma America, Inc. | 1 | $25 |
| Abbott Laboratories | 1 | $24 |
| Exact Sciences Corporation | 1 | $22 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
| Lilly USA, LLC | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Phathom Pharmaceuticals, Inc. | 1 | $13 |
Products named: GEMTESA, PROCLAIM, Cologuard Collection Kit, ELIQUIS, MOUNJARO, QULIPTA, FARXIGA, UBRELVY.
Industry payments across TX — which companies pay providers there.
